Top Markets
Coin of the day
HeraMED Limited HeraMED Limited

HeraMED Limited

HMD
Rank in Stocks #27840
HeraMED Limited and its associated entities are dedicated to the design,... HeraMED Limited and its associated entities are dedicated to the design, production, and sale of at-home fetal heart rate monitors and comprehensive pregnancy monitoring systems. These solutions are offered to consumers throughout Australia, Europe, and Israel. Key products include HeraBEAT, a device enabling expectant mothers to personally track their baby's heartbeat, and HeraCARE, a sophisticated digital platform facilitating the creation and deployment of health solutions for effective maternity care management. The company is also at the forefront of developing EchoBEAT, envisioned as the subsequent evolution of its domestic pregnancy monitoring tools, alongside Orion, an artificial intelligence-driven system engineered for profound pregnancy monitoring analysis. A strategic partnership with Mayo Clinic supports the ongoing advancement of the HeraCARE pregnancy management platform. Established in 2011, HeraMED Limited operates from its main office in Netanya, Israel.
Share Price
$0.02609554
Market Cap
$30.24M
Change (1 day)
0.00%
Change (1 year)
62.24%
Country
AU
Trade HeraMED Limited (HMD)

Category

Number of shares outstanding for HeraMED Limited (HMD)
Number of shares outstanding as of August 2026: 0
According to HeraMED Limited latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for HeraMED Limited (HMD) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
1.74B -
US
383.50M -
US
1.28B -
IE
1.48B -
US
576.40M -
US